Radiolabeled probes targeting hypoxia-inducible factor-1-active tumor microenvironments

Area of Science:

• Oncology
• Molecular Biology
• Medical Imaging

Background:

• Solid tumors develop hypoxic regions due to rapid, random cell growth and inadequate oxygen supply.
• Tumor hypoxia is linked to resistance to chemotherapy and radiotherapy.
• Hypoxia-inducible factor-1 (HIF-1) regulates genes involved in tumor progression and treatment resistance.

Purpose of the Study:

• To review the current status of imaging HIF-1-active regions in tumors.
• To highlight the importance of assessing HIF-1 activity for cancer therapy.
• To discuss the development and application of novel imaging probes and reporter systems.

Main Methods:

• Review of preclinical and clinical studies on HIF-1 imaging.
• Discussion of HIF-1 regulation by its α subunit (HIF-1α) degradation.
• Examination of reporter systems and injectable probes for HIF-1 activity assessment.
• Analysis of (18)F-FDG and (18)F-FMISO as potential indices of HIF-1 activity.

Main Results:

• HIF-1α stabilization under hypoxia enables transcription of target genes.
• Reporter systems and probes targeting HIF-1α degradation pathways show promise in preclinical studies.
• Clinical studies are investigating the utility of (18)F-FDG and (18)F-FMISO for reflecting HIF-1 activity.

Conclusions:

• Direct imaging of HIF-1 activity remains a significant challenge in clinical oncology.
• Current research focuses on developing and validating methods to assess HIF-1 activation.
• Accurate imaging of HIF-1 activity could significantly improve personalized cancer treatment strategies.